- $1.09bn
- $1.06bn
- $259.48m
- 97
- 17
- 88
- 75
Annual income statement for Transcat, fiscal year end - March 30th, USD millions except per share, conversion factor applied.
2020 March 28th | 2021 March 27th | 2022 March 26th | 2023 March 25th | 2024 March 30th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 53 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 173 | 173 | 205 | 231 | 259 |
| Cost of Revenue | |||||
| Gross Profit | 42.5 | 46.1 | 58.4 | 68.4 | 83.8 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 162 | 162 | 191 | 214 | 240 |
| Operating Profit | 10.8 | 11.1 | 14.1 | 16.2 | 19.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 9.73 | 9.98 | 13.2 | 13.5 | 18.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 8.07 | 7.79 | 11.4 | 10.7 | 13.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 8.07 | 7.79 | 11.4 | 10.7 | 13.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 8.07 | 7.79 | 11.4 | 10.7 | 13.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.09 | 1.11 | 1.6 | 1.42 | 1.74 |